214 related articles for article (PubMed ID: 17906845)
21. The NK1 receptor is involved in the antitumoural action of L-733,060 and in the mitogenic action of substance P on neuroblastoma and glioma cell lines.
Muñoz M; Rosso M; Pérez A; Coveñas R; Rosso R; Zamarriego C; Piruat JI
Neuropeptides; 2005 Aug; 39(4):427-32. PubMed ID: 15939468
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the interaction of N-acyl-L-tryptophan benzyl ester neurokinin antagonists with the human neurokinin-1 receptor.
Cascieri MA; Macleod AM; Underwood D; Shiao LL; Ber E; Sadowski S; Yu H; Merchant KJ; Swain CJ; Strader CD
J Biol Chem; 1994 Mar; 269(9):6587-91. PubMed ID: 7509807
[TBL] [Abstract][Full Text] [Related]
23. Role of NK-1 and NK-2 tachykinin receptor antagonism on the growth of human breast carcinoma cell line MDA-MB-231.
Bigioni M; Benzo A; Irrissuto C; Maggi CA; Goso C
Anticancer Drugs; 2005 Nov; 16(10):1083-9. PubMed ID: 16222150
[TBL] [Abstract][Full Text] [Related]
24. Antitumoural action of L-733,060 on neuroblastoma and glioma cell lines.
Muñoz M; Pérez A; Coveñas R; Rosso M; Castro E
Arch Ital Biol; 2004 Mar; 142(2):105-12. PubMed ID: 15248566
[TBL] [Abstract][Full Text] [Related]
25. Fasudil inhibits proliferation and migration of Hep-2 laryngeal carcinoma cells.
Zhang X; Wu N
Drug Des Devel Ther; 2018; 12():373-381. PubMed ID: 29503530
[TBL] [Abstract][Full Text] [Related]
26. Neurokinin-1 receptor: a new promising target in the treatment of cancer.
Muñoz M; Coveñas R
Discov Med; 2010 Oct; 10(53):305-13. PubMed ID: 21034671
[TBL] [Abstract][Full Text] [Related]
27. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
Nizam E; Erin N
Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
[TBL] [Abstract][Full Text] [Related]
28. Neurokinin-1 receptor antagonists as antitumor drugs in gastrointestinal cancer: A new approach.
Muñoz M; Coveñas R
Saudi J Gastroenterol; 2016; 22(4):260-8. PubMed ID: 27488320
[TBL] [Abstract][Full Text] [Related]
29. NK-1 receptor antagonists: a new generation of anticancer drugs.
Munoz M; Covenas R
Mini Rev Med Chem; 2012 Jun; 12(7):593-9. PubMed ID: 22512565
[TBL] [Abstract][Full Text] [Related]
30. Elevated SP/NK-1R in esophageal carcinoma promotes esophageal carcinoma cell proliferation and migration.
Dong J; Feng F; Xu G; Zhang H; Hong L; Yang J
Gene; 2015 Apr; 560(2):205-10. PubMed ID: 25659767
[TBL] [Abstract][Full Text] [Related]
31. Involvement of substance P and the NK-1 receptor in cancer progression.
Muñoz M; Coveñas R
Peptides; 2013 Oct; 48():1-9. PubMed ID: 23933301
[TBL] [Abstract][Full Text] [Related]
32. Neurokinin-1 activation affects EGFR related signal transduction in triple negative breast cancer.
Wang JG; Yu J; Hu JL; Yang WL; Ren H; Ding D; Zhang L; Liu XP
Cell Signal; 2015 Jul; 27(7):1315-24. PubMed ID: 25817575
[TBL] [Abstract][Full Text] [Related]
33. Cancer progression and substance P.
Coveñas R; Muñoz M
Histol Histopathol; 2014 Jul; 29(7):881-90. PubMed ID: 24535838
[TBL] [Abstract][Full Text] [Related]
34. Differential contribution of substance P and neurokinin A to spinal cord neurokinin-1 receptor signaling in the rat.
Trafton JA; Abbadie C; Basbaum AI
J Neurosci; 2001 May; 21(10):3656-64. PubMed ID: 11331395
[TBL] [Abstract][Full Text] [Related]
35. [AMG-102 inhibits proliferation and induces apoptosis of laryngeal squamous cell carcinoma cells by regulating c-Met/PI3K/Akt pathway].
Cao F; Lyu X; Dong KF; Fan C; Zhang JJ; Chen K; Zhang Y; Ma BJ; Hou CL; Zhang CH
Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):99-104. PubMed ID: 32135642
[No Abstract] [Full Text] [Related]
36. Permissive role of neurokinin NK(3) receptors in NK(1) receptor-mediated activation of the locus coeruleus revealed by SR 142801.
Bert L; Rodier D; Bougault I; Allouard N; Le-Fur G; Soubrié P; Steinberg R
Synapse; 2002 Jan; 43(1):62-9. PubMed ID: 11746734
[TBL] [Abstract][Full Text] [Related]
37. NK-1 as a melanoma target.
Muñoz M; Bernabeu-Wittel J; Coveñas R
Expert Opin Ther Targets; 2011 Jul; 15(7):889-97. PubMed ID: 21592000
[TBL] [Abstract][Full Text] [Related]
38. [Effect of c-Met inhibitor AMG-102 on radiosensitivity in laryngeal squamous carcinoma cells].
Cao F; Lyu X; Dong KF; Fan C; Zhang JJ; Chen K; Ma BJ; Hou CL; Zhang CH
Zhonghua Zhong Liu Za Zhi; 2019 Dec; 41(12):909-917. PubMed ID: 31874548
[No Abstract] [Full Text] [Related]
39. Are biological actions of neurokinin A in the adult brain mediated by a cross-talk between the NK1 and NK2 receptors?
Tauer U; Zhao Y; Hunt SP; Culman J
Neuropharmacology; 2012 Nov; 63(6):958-65. PubMed ID: 22771977
[TBL] [Abstract][Full Text] [Related]
40. A new frontier in the treatment of cancer: NK-1 receptor antagonists.
Muñoz M; Rosso M; Coveñas R
Curr Med Chem; 2010; 17(6):504-16. PubMed ID: 20015033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
